STEP 1 Semaglutide The landmark semaglutide trial, published in the New England Journal of Medicine in 2021, randomized 1,961 adults with obesity to semaglutide 2.4 mg weekly or placebo for 68 weeks
The problem surfaces when patients switch pharmacies, titrate to higher doses that force a concentration change, or receive reconstituted vials where the final concentration depends on how much bacteriostatic water was added
This is not a quality issue
However, phentermine is oral (no injections), easier to access as a generic option, and covered by many insurance plans
18 This 2.5 mg dose is intended for treatment initiation to help the body adjust and assess tolerability
Someone starting at BMI 45 might lose 80 pounds (reaching 30% reduction) while someone at BMI 32 loses 40 pounds (achieving 25% reduction)